CVS Health’s iShares 5-10 Year Investment Grade Corporate Bond ETF IGIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.5M Buy
705,000
+265,000
+60% +$13.8M 8.27% 3
2026
Q2
$23.4M Buy
440,000
+347,250
+374% +$18.5M 10.39% 2
2026
Q1
$4.94M Hold
92,750
– – 2.33% 14
2025
Q4
$5M Buy
+92,750
New +$5.01M 3.69% 3

Other funds holding IGIB

CVS Health's IGIB Position: Q3 2026 in Review

CVS Health increased its iShares 5-10 Year Investment Grade Corporate Bond ETF (IGIB) stake by 60% in Q3 2026, buying an estimated $13.8M and bringing the position to 705,000 shares worth $35.5M. The position accounts for 8.27% of the portfolio, ranked #3.

CVS Health first reported a position in IGIB in Q4 2025 and has held it in 4 quarters since. 727 funds tracked by Wall St. Rank hold IGIB as of Q3 2026.

  • CVS Health held 705,000 shares of iShares 5-10 Year Investment Grade Corporate Bond ETF worth $35.5M as of Q3 2026.
  • CVS Health bought 265,000 iShares 5-10 Year Investment Grade Corporate Bond ETF shares in Q3 2026, an estimated $13.8M.
  • iShares 5-10 Year Investment Grade Corporate Bond ETF made up 8.27% of CVS Health's portfolio in Q3 2026, its #3 holding.
  • CVS Health first reported a position in iShares 5-10 Year Investment Grade Corporate Bond ETF in Q4 2025 and has held it in 4 quarters since.
  • 727 funds tracked by Wall St. Rank held iShares 5-10 Year Investment Grade Corporate Bond ETF as of Q3 2026.

Based on CVS Health's 13F filing for Q3 2026, filed 5 Nov 2026.